Ambrose Allison sold 485 Upstream Bio shares at $5.49 per share on 2026-09-16, leaving 15,563 shares after the transaction. For investors, the reported sale amounted to about 3.0% of Allison’s prior Upstream Bio share holding, while transaction code S classified it as an open-market sale.

Key Highlights

  • Upstream Bio shares changed hands at $5.49 each in Ambrose Allison’s transaction.
  • Allison’s reported Upstream Bio balance after the trade was 15,563 shares.
  • Transaction code S categorised the activity as an open-market sale dated 16 September 2026.

Ambrose Allison sold 485 shares of Upstream Bio, Inc. (NASDAQ: UPB) at $5.49 per share. The transaction took place on 16 September 2026, and Allison retained 15,563 shares afterward. The reported sale represented about 3.0% of Allison’s prior Upstream Bio share holding.

Sale Compared With Prior Holding

The stated 3.0% figure measures the transaction against Allison’s prior shares holding in Upstream Bio. The reported balance after the transaction remained 15,563 shares.